The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ADDEX THERAPEUTICS LTD SPONSORED ADS 00654J107 213 17,398 SH   SOLE   17,398 0 0
CARDIFF ONCOLOGY INC COM 14147L108 26,183 1,845,164 SH   SOLE   1,845,164 0 0
CHURCHILL CAPITAL CORP IV UNIT 99/99/9999 171439201 626 62,500 SH   SOLE   62,500 0 0
CTI BIOPHARMA CORP COM 12648L601 9,274 4,313,617 SH   SOLE   4,313,617 0 0
EIGER BIOPHARMACEUTICALS INC COM 28249U105 919 112,872 SH   SOLE   112,872 0 0
ESSA PHARMA INC COM NEW 29668H708 183 26,590 SH   SOLE   26,590 0 0
GARRISON CAP INC COM 366554103 4,447 1,164,061 SH   SOLE   1,164,061 0 0
IVERIC BIO INC COM 46583P102 1,087 192,738 SH   SOLE   192,738 0 0
KALA PHARMACEUTICALS INC COM 483119103 5,788 771,790 SH   SOLE   771,790 0 0
MEI PHARMA INC COM NEW 55279B202 548 175,560 SH   SOLE   175,560 0 0
MOLECULAR TEMPLATES INC COM 608550109 23,183 2,122,991 SH   SOLE   2,122,991 0 0
PERSHING SQUARE TONTINE HLDG COM CL A 71531R109 1,529 67,369 SH   SOLE   67,369 0 0
PERSHING SQUARE TONTINE HLDG *W EXP 07/24/202 71531R117 54 7,485 SH   SOLE   7,485 0 0
SCYNEXIS INC COM NEW 811292200 3,680 834,370 SH   SOLE   834,370 0 0
SIERRA ONCOLOGY INC COM NEW 82640U404 6,871 643,959 SH   SOLE   643,959 0 0
SPDR GOLD TR GOLD SHS 78463V107 4,491 25,358 SH   SOLE   25,358 0 0
STRONGBRIDGE BIOPHARMA PLC SHS USD G85347105 16,988 8,089,442 SH   SOLE   8,089,442 0 0